NPI: 1306024294 · BENTONVILLE, AR 72712 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 02/04/2008
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 02/04/2008 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 6,943 | $78K |
| 2019 | 6,364 | $84K |
| 2020 | 15,124 | $180K |
| 2021 | 12,522 | $112K |
| 2022 | 10,128 | $89K |
| 2023 | 1,906 | $20K |
| 2024 | 1,055 | $16K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 83970 | 1,355 | 1,040 | $195K | |
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 20,428 | 1,535 | $116K |
| 82728 | 639 | 550 | $73K | |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 17,903 | 1,065 | $64K |
| 83550 | 655 | 554 | $36K | |
| 83540 | 656 | 554 | $31K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 140 | 116 | $30K |
| 82108 | 62 | 48 | $14K | |
| J1270 | Injection, doxercalciferol, 1 mcg | 6,007 | 527 | $6K |
| A4657 | Syringe, with or without needle, each | 1,091 | 961 | $5K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 119 | 62 | $3K |
| 85041 | 1,073 | 915 | $2K | |
| J1756 | Injection, iron sucrose, 1 mg | 2,386 | 597 | $1K |
| 85048 | 1,066 | 909 | $1K | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 354 | 181 | $1K |
| 82607 | 43 | 31 | $245.03 | |
| 82746 | 19 | 19 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 22 | 15 | $0.00 |
| 90674 | 24 | 16 | $0.00 |